The Indian Journal of Pediatrics

, Volume 63, Issue 2, pp 159–162 | Cite as

Multi drug resistant tuberculosis

  • Kamlesh Chopra
Symposium: Pulmonology Part-II

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Isemann MD. Treatment of multidrug resistant tuberculosis.N Engl J Med 1993; 329:784–791.CrossRefGoogle Scholar
  2. 2.
    Dooley SW, Jarvis WR, Martone WJet al. Multidrug resistant tuberculosis.Ann Intern Med 1992;117:257–258.PubMedGoogle Scholar
  3. 3.
    Raviglione MC, Snider Snider DE, Kochi A. Global epidemiology of tuberculosis Morbidity and Mortality of a world wide epidemic.JAMA 1995;273:220–226.PubMedCrossRefGoogle Scholar
  4. 4.
    Vareldzis BP, Grosset J, Kantor IDet al. Laboratory evaluation of drug resistant tuberculosis. Document WHO/TB. 1993; 171:3–16.Google Scholar
  5. 5.
    Heym B, Cole ST. Isolation and characterization of isoniazid-resistant mutants of M. Smegmatis.Res Microbiol 143:721–730.Google Scholar
  6. 6.
    Cole ST. Mechanisms of drug resistance in Mycobacterium tuberculosis.Immunobiol 1994;191:584–585.Google Scholar
  7. 7.
    Winder FG, Collins PB. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis.J Gen Microbiol 1970;63:41–48.PubMedGoogle Scholar
  8. 8.
    Freiden TR, Sterling T, Pablos M. The emergence of drug resistant tuberculosis in New York City.N Engl J Med 1993;328:521–526.CrossRefGoogle Scholar
  9. 9.
    Goble M, Iseman MD, Madsen LAet al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin.N Engl J Med 1993;328:527–532.PubMedCrossRefGoogle Scholar
  10. 10.
    Snider DE, Cauthen GM, Farer LSet al. Drug resistant tuberculosis.Am Rev Respir Dis 1991;144:732–736.PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1996

Authors and Affiliations

  • Kamlesh Chopra
    • 1
  1. 1.Department of PediatricsMaulana Azad Medical CollegeNew Delhi

Personalised recommendations